Dominance of Small-Molecule Drugs

Small-molecule pharmaceuticals have long served as a cornerstone of therapeutic treatment due to their versatility and effectiveness. This segment will explore current trends in small-molecule drug development, emphasizing innovations in drug design and targeted therapies, particularly in the field of oncology. It will also cover advancements in oral drug delivery systems, key safety considerations, and evolving global market dynamics.

Sub-Sessions:

Related Conference of Pharmaceutical Sciences